Based on existing evidence, a definitive correlation between the ANXA2 gene and MS has not been demonstrated, even if it has been shown to be involved in facilitating the traversal of the blood–brain barrier, a protective barrier that safeguards the central nervous system [88]. Here, ANXA2 is linked to myeloid sarcoma.